Senator Chuck Grassley, along with Senator Sherrod Brown and Senator Richard Blumenthal recently introduced bipartisan legislation that is expected to increase transparency in the prescription drug payment process, S. 2891, The “Fighting the Opioid Epidemic with Sunshine Act.”
The Fighting the Opioid Epidemic with Sunshine Act will require drug companies and medical device makers to publicly disclose the same payments made to nurse practitioners and physician assistants for promotional talks, consulting, and other interactions. Nurse practitioners and physician assistants write a significant number of prescriptions and should be included in these disclosures.
The Senators believe that “by shining a light on the relationship between drug companies and prescriptions for opioids, greater accountability will be achieved.” Each of the three introducing Senators released a statement on the topic.
To read the article by Thomas Sullivan
